tiprankstipranks
TipRanksTop Financial ExpertsInsidersNew Enterprise Associates 17, L.P.

New Enterprise Associates 17, L.P. Insider Profile

4 Followers
New Enterprise Associates 17, L.P., Ten Percent Owner at Monte Rosa Therapeutics, holds 1.30M shares in Korro Bio (Ticker: KRRO), holds 6.04M shares in SpyGlass Pharma (Ticker: SGP), holds 0.00 shares in NeueHealth Inc (Ticker: NEUE). Most recently, New Enterprise Associates 17, L.P. Bought ― shares of Korro Bio on Mar 12, 2026 for an estimated value of $2.30M.
tipranks
New Enterprise Associates 17, L.P.

New Enterprise Associates 17, L.P.
Monte Rosa Therapeutics (GLUE)
Ten Percent Owner

Ranked #95,332 out of 106,324 Corporate Insiders

Profitable Transactions

0%
0 out of 5 Profitable Transactions

Average Return

-37.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$399M
39.98%
30.94%
25.33%
3.74%
A breakdown of New Enterprise Associates 17, L.P.'s holdings

Insider Roles

SpyGlass Pharma
(SGP)
Ten Percent Owner
Monte Rosa Therapeutics
(GLUE)
Ten Percent Owner
MBX Biosciences, Inc.
(MBX)
Ten Percent Owner
Korro Bio
(KRRO)
Ten Percent Owner
Roles that New Enterprise Associates 17, L.P. holds in companies

Most Profitable Insider Trade

Stock:
NeueHealth Inc
(NEUE)
Rating:Informative Buy
Date:Oct 06, 2025 - Today
Return:0.00%
The most profitable trade made by New Enterprise Associates 17, L.P.

New Enterprise Associates 17, L.P.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Monte Rosa Therapeutics
Jun 30, 2021
Ten Percent Owner
Uninformative Buy
$123.38M
NEUE
NeueHealth Inc
Oct 06, 2025
Uninformative Buy
1.86K
$0.00
Korro Bio
Mar 12, 2026
Ten Percent Owner
Informative Buy
2.30M
$14.93M
MBX Biosciences, Inc.
Sep 17, 2024
Ten Percent Owner
Uninformative Buy
$101.02M
SpyGlass Pharma
Feb 11, 2026
Ten Percent Owner
Uninformative Buy
$159.45M
List of latest transactions for each holding click on a transaction to see New Enterprise Associates 17, L.P.'s performance on stock

New Enterprise Associates 17, L.P. insider profile FAQ

What is the percentage of profitable transactions made by New Enterprise Associates 17, L.P.?
The percentage of profitable transactions made by New Enterprise Associates 17, L.P. is 0%.
    What is the average return per transaction made by New Enterprise Associates 17, L.P.?
    The average return per transaction made by New Enterprise Associates 17, L.P. is -37.30%.
      What stocks does New Enterprise Associates 17, L.P. hold?
      New Enterprise Associates 17, L.P. holds: GLUE, NEUE, KRRO, MBX, SGP stocks.
        What was New Enterprise Associates 17, L.P.’s latest transaction?
        New Enterprise Associates 17, L.P. latest transaction was an Informative Buy of $2.30M.
          What was New Enterprise Associates 17, L.P.'s most profitable transaction?
          New Enterprise Associates 17, L.P.’s most profitable transaction was an Informative Buy of NEUE stock on October 6, 2025. The return on the trade was 0.00%.
            What is New Enterprise Associates 17, L.P.'s role in Monte Rosa Therapeutics?
            New Enterprise Associates 17, L.P.'s role in Monte Rosa Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.